ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Apretude Drugs
December 27, 2021ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders... -
FDA approves ViiV Healthcare’s Apretude for HIV prevention Pharmaceutical-Business-Review
December 22, 2021The long-acting injectable is indicated for use in adults and adolescents who are at risk of sexually acquiring HIV and test negative for HIV-1 before initiation. -
First Long-Acting Injectable Approved for HIV PrEP drugs.com
December 21, 2021The U.S. Food and Drug Administration has approved the first long-acting injectable treatment for HIV preexposure prophylaxis, which is given every two months and offers an alternative to daily oral medication, the agency announced Monday.
Pharma Sources Insight January 2025
